Loss of chromosome 8p governs tumor progression and drug response by altering lipid metabolism Y Cai, J Crowther, T Pastor, LA Asbagh, MF Baietti, M De Troyer, ... Cancer cell 29 (5), 751-766, 2016 | 176 | 2016 |
Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination M Steklov, S Pandolfi, MF Baietti, A Batiuk, P Carai, P Najm, M Zhang, ... Science 362 (6419), 1177-1182, 2018 | 152 | 2018 |
p16INK4a impairs homologous recombination–mediated DNA repair in human papillomavirus–positive head and neck tumors R Dok, P Kalev, EJ Van Limbergen, LA Asbagh, I Vázquez, E Hauben, ... Cancer research 74 (6), 1739-1751, 2014 | 127 | 2014 |
Recurrent PPP2R1A Mutations in Uterine Cancer Act through a Dominant-Negative Mechanism to Promote Malignant Cell Growth D Haesen, L Abbasi Asbagh, R Derua, A Hubert, S Schrauwen, Y Hoorne, ... Cancer research 76 (19), 5719-5731, 2016 | 105 | 2016 |
OTUB 1 triggers lung cancer development by inhibiting RAS monoubiquitination MF Baietti, M Simicek, L Abbasi Asbagh, E Radaelli, S Lievens, ... EMBO molecular medicine 8 (3), 288-303, 2016 | 94 | 2016 |
The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling LA Asbagh, I Vazquez, L Vecchione, E Budinska, V De Vriendt, MF Baietti, ... Oncotarget 5 (20), 10070, 2014 | 33 | 2014 |
Feedback activation of HER3 attenuates response to EGFR inhibitors in colon cancer cells A Bosch-Vilaró, B Jacobs, V Pomella, LA Asbagh, R Kirkland, J Michel, ... Oncotarget 8 (3), 4277, 2017 | 30 | 2017 |
Nuclear p16INK4a expression predicts enhanced radiation response in head and neck cancers R Dok, LA Asbagh, EJ Van Limbergen, A Sablina, S Nuyts Oncotarget 7 (25), 38785, 2016 | 17 | 2016 |
Zoledronic acid effects interleukin-6 expression in hormone-independent prostate cancer cell lines LA Asbagh, S Uzunoglu, C Cal International braz j urol 34, 355-364, 2008 | 10 | 2008 |
Translational perspective of mathematical models used in the assessment of cellular synergy in cytotoxicity assays LA ASBAGH, A DENİZ, S UZUNOĞLU, U Rüçhan Celal Bayar University Journal of Science 4 (1), 127-134, 2008 | 3 | 2008 |
Loss-of-function of ubiquitin ligase adaptor LZTR1 triggers human disease by dysregulating RAS ubiquitination M Steklov, S Pandolfi, MF Baietti, P Najm, P Carai, M Zhang, H Jang, ... Programme Book, 11-11, 2017 | | 2017 |
Role of RAS ubiquitination in cancer development MF Baietti, M Steklov, J Crowther, M Simicek, L Abbasi Asbagh, ... Copenhagen Bioscience Conference on'Protein Signaling: from pathways to …, 2016 | | 2016 |
OC-0439: Localization of p16 expression is an important factor to determine radiotherapy response in HNSCC R Dok, LA Asbagh, E Van Limbergen, A Sablina, S Nuyts Radiotherapy and Oncology 119, S204-S205, 2016 | | 2016 |
The role of protein tyrosine phosphatase receptor type 0 (PTPRO) in colon cancer L Abbasi Asbagh | | 2016 |
Uterine cancer-associated PPP2R1A mutations increase cancer cell growth by a dominant mechanism-of-action D Haesen, LA Asbach, R Derua, A Hubert, S Schrauwen, Y Hoorne, ... Biochemical and functional characterization of disease-associated …, 2016 | | 2016 |
OTUB1 promotes KRAS wild-type lung cancers development by inhibiting RAS mono-and di-ubiquitination MF Baietti, M Simicek, L Abbasi A, E Radaelli, S Lievens, J Crowther, ... Molecular Biology of the Cell 26 (25), 2015 | | 2015 |
The role of lincRNAs in breast cancer T Pastor, J Crowther, L Abbasi A, MF Baietti, M Fiers, AA Sablina EMBO symposium, 2015 | | 2015 |
Endometrial and ovarian carcinoma-associated PPP2R1A mutations increase cancer cell aggressiveness through a dominant-negative mechanism D Haesen, L Abbasi Asbagh, A Hubert, R Derua, S Schrauwen, Y Hoorne, ... LKI Oncoforum 2015, Date: 2015/06/05-2015/06/05, Location: Leuven, BE, 2015 | | 2015 |
PTPRO silencing by MAPK pathway in colorectal cancer L Vecchione, AF Narzo, LA Asbagh, S Tejpar Cancer Research 72 (8_Supplement), 4162-4162, 2012 | | 2012 |
PTPRO as a candidate phosphatase in regulating EGFR signaling in colorectal cancer LA Asbagh, L Vecchione, A Sablina, S Tejpar Cancer Research 72 (8_Supplement), 1218-1218, 2012 | | 2012 |